Locana CEO and leadership

Jim Burns is a Chief Executive Officer at Locana and is based in Boston, Massachusetts. He has worked as Head of R&D at SANOFI, Senior VP:Biosurgery Product Dev at Genzyme Surgical Products Corp, and President and CEO at CASEBIA THERAPEUTICS LLP. Jim attended Purdue University between 1973 and 1977, University of Illinois Urbana Champaign, and University of Illinois Chicago between 1978 and 1984.

Edward Conner is a Board Member at IMARA INC., Chief Medical Officer at Critigen, and Chief Medical Officer at Locana and is based in San Francisco Bay Area. He has worked as Senior VP/Chief Medical Ofcr at SANGAMO THERAPEUTICS INC, Senior VP/Chief Medical Officer at AUDENTES THERAPEUTICS INC., and Dir:Medical at Genentech Inc.. Edward studied at Duke University, The Johns Hopkins University School of Medicine between 2003 and 2006, and University of Melbourne.

John Leonard is a Chief Scientific Officer at Locanabio Inc. and is based in San Diego, California. He has worked as Head of Metabolic & Muscle Rare Disease Research at SANOFI, Head of In Vivo & Hematology Research and Translation at CRISPR Therapeutics Inc, and VP Preclinical Pharmacology at SANOFI. John attended King s College London.

Ms. Lange joined Locanabio in September 2021 from J.P. Morgan where she was most recently an executive director in the healthcare investment banking group. During her time at J.P. Morgan, she executed more than $18 billion in equity and equity-linked financings and more than $27 billion in various business transactions. Ms. Lange joined J.P. Morgan in 2009 in their London office before transferring to the San Francisco office in 2013. She earned a master’s degree in management science from the Judge Business School at Cambridge University and a master’s and bachelor’s degree in natural sciences also from Cambridge University.

Before joining Locana, Mr. Mackison was Senior Vice President, Corporate Development and Strategy at Assembly Biosciences where he led business development efforts since 2015. Prior to his work at Assembly, he was Senior Director, Corporate Investment at Jabil Healthcare & Life Sciences where he led healthcare transactions. Previously, Mr. Mackison served as Head of Corporate Strategy and Senior Director, New Ventures at H. Lundbeck A/S focused on neuroscience. Prior to the acquisition by Lundbeck, he was Director, Corporate Development and M&A at Ovation Pharmaceuticals, a rare disease, neuroscience company that launched the first product for Huntington's Disease. He previously held financial roles at Eli Lilly and Pfizer. Mr. Mackison earned a Bachelor of Science degree in Finance from Indiana University.

Jim Burns is a Chief Executive Officer at Locana and is based in Boston, Massachusetts. He has worked as Head of R&D at SANOFI, Senior VP:Biosurgery Product Dev at Genzyme Surgical Products Corp, and President and CEO at CASEBIA THERAPEUTICS LLP. Jim attended Purdue University between 1973 and 1977, University of Illinois Urbana Champaign, and University of Illinois Chicago between 1978 and 1984.

Edward Conner is a Board Member at IMARA INC., Chief Medical Officer at Critigen, and Chief Medical Officer at Locana and is based in San Francisco Bay Area. He has worked as Senior VP/Chief Medical Ofcr at SANGAMO THERAPEUTICS INC, Senior VP/Chief Medical Officer at AUDENTES THERAPEUTICS INC., and Dir:Medical at Genentech Inc.. Edward studied at Duke University, The Johns Hopkins University School of Medicine between 2003 and 2006, and University of Melbourne.